For Sun Pharma, its investment in speciality business is paying off, as it is becoming a driver of growth for the company’s US business. Cipla’s ‘One India’ strategy, focusing on branded prescription, trade generics and consumer health brands, is leading to continued core portfolio momentum across businesses.
Urban Company shares surge 7% to 11-month high, rally 16% in 2 sessions. Here are 2 reasons why
Urban Company shares rallied on Monday, after a bullish brokerage call and a legal development involving Kent RO. Kent RO has agreed to remove advertisements